Table 1. pD2 and Emax values for ACh-induced dilation in arteries from WKY and SHRSP.
WKY | SHRSP | |||
---|---|---|---|---|
pD2 | Emax | pD2 | Emax | |
Vehicle | 8.0±0.01 | 102.2±1.4 | 8.2±0.11* | 87.7±5.8* |
L-NAME + Indomethacin | 7.8±0.08* | 100.6±0.6 | 7.8±0.22 | 38.4±1.6*† |
Iberiotoxin L-NAME + Indomethacin |
7.6±0.01 | 94.2±1.8 | 6.4±0.02*‡ | 50.7±3.6*‡ |
UCL-1684 L-NAME + Indomethacin |
6.7±0.03‡ | 17.3±2.4‡ | 8.1±0.15*‡ | 14.6±2.4‡ |
TRAM-34 L-NAME + Indomethacin |
7.5±0.07 | 86.0±2.7‡ | 7.4±0.12*‡ | 7.5±0.5*‡ |
Charybdotoxin L-NAME + Indomethacin |
7.4±0.04 | 97.4±0.9‡ | 7.8±0.31*‡ | 7.4±0.01‡ |
UCL-1684 + TRAM-34 L-NAME + Indomethacin |
7.1±0.02‡ | 8.6±1.5‡ | 6.6±0.15*‡ | 7.3±1.1‡ |
P<0.05 vs. WKY
P<0.05 vs. respective vehicle-treated
P<0.05 vs. respective L-NAME and indomethacin-treated.